Screening of antigenic vesicular fluid proteins of Echinococcus multilocularis as potential viability biomarkers to monitor drug response in alveolar echinococcosis patients.

Benoît ValotBénédicte RognonAnais PrenelAlice BaraquinJenny KnappMathilde AnelliCarine RichouSolange Bresson-HadniFrederic GrenouilletJunhua WangDominique Angèle VuittonBruno GottsteinLaurence Millon

Published in: Proteomics. Clinical applications (2017)

Detection of antibodies against these proteins by ELISA could be helpful to monitor the course of alveolar echinococcosis under albendazole (ABZ) treatment.

Keyphrases

end stage renal disease
chronic kidney disease
emergency department
risk assessment
patient reported outcomes
combination therapy
replacement therapy
loop mediated isothermal amplification
drug induced
real time pcr
sensitive detection